Coalition Says Transparency, Value-Based Pay Could Contain Drug Costs Last Updated: April 26, 2016
Filed under:
Print Friendly, PDF & Email

Modern Healthcare: Increased transparency and competition in the pharmaceutical industry and expanded value-based payment models would help address rising prescription drug prices, according to a coalition aimed at containing costs.
The Campaign for Sustainable Rx Pricing said multiple organizations representing doctors, nurses, hospitals, insurers and consumers have endorsed the proposals to fix what they say is a broken market for prescription drugs. Premier COO Michael Alkire said the group purchasing organization supports the proposal.

Full story